Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis.

Identifieur interne : 002714 ( PubMed/Corpus ); précédent : 002713; suivant : 002715

Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis.

Auteurs : Chung Y. Cheung ; Leo L M. Poon ; Iris H Y. Ng ; Winsie Luk ; Sin-Fun Sia ; Mavis H S. Wu ; Kwok-Hung Chan ; Kwok-Yung Yuen ; Siamon Gordon ; Yi Guan ; Joseph S M. Peiris

Source :

RBID : pubmed:15919935

English descriptors

Abstract

The pathogenesis of severe acute respiratory syndrome (SARS) remains unclear. Macrophages are key sentinel cells in the respiratory system, and it is therefore relevant to compare the responses of human macrophages to infections with the SARS coronavirus (SARS-CoV) and other respiratory viruses. Primary human monocyte-derived macrophages were infected with SARS-CoV in vitro. Virus replication was monitored by measuring the levels of positive- and negative-strand RNA, by immunofluorescence detection of the SARS-CoV nucleoprotein, and by titration of the infectious virus. The gene expression profiles of macrophages infected with SARS-CoV, human coronavirus 229E, and influenza A (H1N1) virus were compared by using microarrays and real-time quantitative reverse transcriptase PCR. Secreted cytokines were measured with an enzyme-linked immunosorbent assay. SARS-CoV initiated viral gene transcription and protein synthesis in macrophages, but replication was abortive and no infectious virus was produced. In contrast to the case with human coronavirus 229E and influenza A virus, there was little or no induction of beta interferon (IFN-beta) in SARS-CoV-infected macrophages. Furthermore, SARS-CoV induced the expression of chemokines such as CXCL10/IFN-gamma-inducible protein 10 and CCL2/monocyte chemotactic protein 1. The poor induction of IFN-beta, a key component of innate immunity, and the ability of the virus to induce chemokines could explain aspects of the pathogenesis of SARS.

DOI: 10.1128/JVI.79.12.7819-7826.2005
PubMed: 15919935

Links to Exploration step

pubmed:15919935

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis.</title>
<author>
<name sortKey="Cheung, Chung Y" sort="Cheung, Chung Y" uniqKey="Cheung C" first="Chung Y" last="Cheung">Chung Y. Cheung</name>
<affiliation>
<nlm:affiliation>Department of Microbiology, University Pathology Building, Queen Mary Hospital, Pokfulam Road, Hong Kong, Special Administrative Region, People's Republic of China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Poon, Leo L M" sort="Poon, Leo L M" uniqKey="Poon L" first="Leo L M" last="Poon">Leo L M. Poon</name>
</author>
<author>
<name sortKey="Ng, Iris H Y" sort="Ng, Iris H Y" uniqKey="Ng I" first="Iris H Y" last="Ng">Iris H Y. Ng</name>
</author>
<author>
<name sortKey="Luk, Winsie" sort="Luk, Winsie" uniqKey="Luk W" first="Winsie" last="Luk">Winsie Luk</name>
</author>
<author>
<name sortKey="Sia, Sin Fun" sort="Sia, Sin Fun" uniqKey="Sia S" first="Sin-Fun" last="Sia">Sin-Fun Sia</name>
</author>
<author>
<name sortKey="Wu, Mavis H S" sort="Wu, Mavis H S" uniqKey="Wu M" first="Mavis H S" last="Wu">Mavis H S. Wu</name>
</author>
<author>
<name sortKey="Chan, Kwok Hung" sort="Chan, Kwok Hung" uniqKey="Chan K" first="Kwok-Hung" last="Chan">Kwok-Hung Chan</name>
</author>
<author>
<name sortKey="Yuen, Kwok Yung" sort="Yuen, Kwok Yung" uniqKey="Yuen K" first="Kwok-Yung" last="Yuen">Kwok-Yung Yuen</name>
</author>
<author>
<name sortKey="Gordon, Siamon" sort="Gordon, Siamon" uniqKey="Gordon S" first="Siamon" last="Gordon">Siamon Gordon</name>
</author>
<author>
<name sortKey="Guan, Yi" sort="Guan, Yi" uniqKey="Guan Y" first="Yi" last="Guan">Yi Guan</name>
</author>
<author>
<name sortKey="Peiris, Joseph S M" sort="Peiris, Joseph S M" uniqKey="Peiris J" first="Joseph S M" last="Peiris">Joseph S M. Peiris</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15919935</idno>
<idno type="pmid">15919935</idno>
<idno type="doi">10.1128/JVI.79.12.7819-7826.2005</idno>
<idno type="wicri:Area/PubMed/Corpus">002714</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002714</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis.</title>
<author>
<name sortKey="Cheung, Chung Y" sort="Cheung, Chung Y" uniqKey="Cheung C" first="Chung Y" last="Cheung">Chung Y. Cheung</name>
<affiliation>
<nlm:affiliation>Department of Microbiology, University Pathology Building, Queen Mary Hospital, Pokfulam Road, Hong Kong, Special Administrative Region, People's Republic of China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Poon, Leo L M" sort="Poon, Leo L M" uniqKey="Poon L" first="Leo L M" last="Poon">Leo L M. Poon</name>
</author>
<author>
<name sortKey="Ng, Iris H Y" sort="Ng, Iris H Y" uniqKey="Ng I" first="Iris H Y" last="Ng">Iris H Y. Ng</name>
</author>
<author>
<name sortKey="Luk, Winsie" sort="Luk, Winsie" uniqKey="Luk W" first="Winsie" last="Luk">Winsie Luk</name>
</author>
<author>
<name sortKey="Sia, Sin Fun" sort="Sia, Sin Fun" uniqKey="Sia S" first="Sin-Fun" last="Sia">Sin-Fun Sia</name>
</author>
<author>
<name sortKey="Wu, Mavis H S" sort="Wu, Mavis H S" uniqKey="Wu M" first="Mavis H S" last="Wu">Mavis H S. Wu</name>
</author>
<author>
<name sortKey="Chan, Kwok Hung" sort="Chan, Kwok Hung" uniqKey="Chan K" first="Kwok-Hung" last="Chan">Kwok-Hung Chan</name>
</author>
<author>
<name sortKey="Yuen, Kwok Yung" sort="Yuen, Kwok Yung" uniqKey="Yuen K" first="Kwok-Yung" last="Yuen">Kwok-Yung Yuen</name>
</author>
<author>
<name sortKey="Gordon, Siamon" sort="Gordon, Siamon" uniqKey="Gordon S" first="Siamon" last="Gordon">Siamon Gordon</name>
</author>
<author>
<name sortKey="Guan, Yi" sort="Guan, Yi" uniqKey="Guan Y" first="Yi" last="Guan">Yi Guan</name>
</author>
<author>
<name sortKey="Peiris, Joseph S M" sort="Peiris, Joseph S M" uniqKey="Peiris J" first="Joseph S M" last="Peiris">Joseph S M. Peiris</name>
</author>
</analytic>
<series>
<title level="j">Journal of virology</title>
<idno type="ISSN">0022-538X</idno>
<imprint>
<date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Cells, Cultured</term>
<term>Chemokine CCL2 (genetics)</term>
<term>Chemokine CCL2 (metabolism)</term>
<term>Chemokine CXCL10</term>
<term>Chemokines, CXC (genetics)</term>
<term>Chemokines, CXC (metabolism)</term>
<term>Cytokines (genetics)</term>
<term>Cytokines (metabolism)</term>
<term>Gene Expression Profiling</term>
<term>Humans</term>
<term>Macrophages (immunology)</term>
<term>Macrophages (virology)</term>
<term>Mice</term>
<term>Oligonucleotide Array Sequence Analysis</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
<term>SARS Virus (pathogenicity)</term>
<term>Severe Acute Respiratory Syndrome (immunology)</term>
<term>Severe Acute Respiratory Syndrome (virology)</term>
<term>Viral Proteins (genetics)</term>
<term>Viral Proteins (metabolism)</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Chemokine CCL2</term>
<term>Chemokines, CXC</term>
<term>Cytokines</term>
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Chemokine CCL2</term>
<term>Chemokines, CXC</term>
<term>Cytokines</term>
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Macrophages</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Macrophages</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cells, Cultured</term>
<term>Chemokine CXCL10</term>
<term>Gene Expression Profiling</term>
<term>Humans</term>
<term>Mice</term>
<term>Oligonucleotide Array Sequence Analysis</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
<term>Virus Replication</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The pathogenesis of severe acute respiratory syndrome (SARS) remains unclear. Macrophages are key sentinel cells in the respiratory system, and it is therefore relevant to compare the responses of human macrophages to infections with the SARS coronavirus (SARS-CoV) and other respiratory viruses. Primary human monocyte-derived macrophages were infected with SARS-CoV in vitro. Virus replication was monitored by measuring the levels of positive- and negative-strand RNA, by immunofluorescence detection of the SARS-CoV nucleoprotein, and by titration of the infectious virus. The gene expression profiles of macrophages infected with SARS-CoV, human coronavirus 229E, and influenza A (H1N1) virus were compared by using microarrays and real-time quantitative reverse transcriptase PCR. Secreted cytokines were measured with an enzyme-linked immunosorbent assay. SARS-CoV initiated viral gene transcription and protein synthesis in macrophages, but replication was abortive and no infectious virus was produced. In contrast to the case with human coronavirus 229E and influenza A virus, there was little or no induction of beta interferon (IFN-beta) in SARS-CoV-infected macrophages. Furthermore, SARS-CoV induced the expression of chemokines such as CXCL10/IFN-gamma-inducible protein 10 and CCL2/monocyte chemotactic protein 1. The poor induction of IFN-beta, a key component of innate immunity, and the ability of the virus to induce chemokines could explain aspects of the pathogenesis of SARS.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">15919935</PMID>
<DateCompleted>
<Year>2005</Year>
<Month>06</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0022-538X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>79</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2005</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis.</ArticleTitle>
<Pagination>
<MedlinePgn>7819-26</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The pathogenesis of severe acute respiratory syndrome (SARS) remains unclear. Macrophages are key sentinel cells in the respiratory system, and it is therefore relevant to compare the responses of human macrophages to infections with the SARS coronavirus (SARS-CoV) and other respiratory viruses. Primary human monocyte-derived macrophages were infected with SARS-CoV in vitro. Virus replication was monitored by measuring the levels of positive- and negative-strand RNA, by immunofluorescence detection of the SARS-CoV nucleoprotein, and by titration of the infectious virus. The gene expression profiles of macrophages infected with SARS-CoV, human coronavirus 229E, and influenza A (H1N1) virus were compared by using microarrays and real-time quantitative reverse transcriptase PCR. Secreted cytokines were measured with an enzyme-linked immunosorbent assay. SARS-CoV initiated viral gene transcription and protein synthesis in macrophages, but replication was abortive and no infectious virus was produced. In contrast to the case with human coronavirus 229E and influenza A virus, there was little or no induction of beta interferon (IFN-beta) in SARS-CoV-infected macrophages. Furthermore, SARS-CoV induced the expression of chemokines such as CXCL10/IFN-gamma-inducible protein 10 and CCL2/monocyte chemotactic protein 1. The poor induction of IFN-beta, a key component of innate immunity, and the ability of the virus to induce chemokines could explain aspects of the pathogenesis of SARS.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cheung</LastName>
<ForeName>Chung Y</ForeName>
<Initials>CY</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology, University Pathology Building, Queen Mary Hospital, Pokfulam Road, Hong Kong, Special Administrative Region, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Poon</LastName>
<ForeName>Leo L M</ForeName>
<Initials>LL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ng</LastName>
<ForeName>Iris H Y</ForeName>
<Initials>IH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Luk</LastName>
<ForeName>Winsie</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sia</LastName>
<ForeName>Sin-Fun</ForeName>
<Initials>SF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Mavis H S</ForeName>
<Initials>MH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chan</LastName>
<ForeName>Kwok-Hung</ForeName>
<Initials>KH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yuen</LastName>
<ForeName>Kwok-Yung</ForeName>
<Initials>KY</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gordon</LastName>
<ForeName>Siamon</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Guan</LastName>
<ForeName>Yi</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Peiris</LastName>
<ForeName>Joseph S M</ForeName>
<Initials>JS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>N01AI95357</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C111835">CCL2 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C114753">CXCL10 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018932">Chemokine CCL2</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054357">Chemokine CXCL10</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019743">Chemokines, CXC</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018932" MajorTopicYN="N">Chemokine CCL2</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054357" MajorTopicYN="N">Chemokine CXCL10</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019743" MajorTopicYN="N">Chemokines, CXC</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020411" MajorTopicYN="N">Oligonucleotide Array Sequence Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2005</Year>
<Month>5</Month>
<Day>28</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2005</Year>
<Month>6</Month>
<Day>29</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2005</Year>
<Month>5</Month>
<Day>28</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">15919935</ArticleId>
<ArticleId IdType="pii">79/12/7819</ArticleId>
<ArticleId IdType="doi">10.1128/JVI.79.12.7819-7826.2005</ArticleId>
<ArticleId IdType="pmc">PMC1143636</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Nat Immunol. 2003 Jan;4(1):63-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12469119</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Comp Immunol Microbiol Infect Dis. 1981;4(2):175-89</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6754243</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Chem. 2004 Jan;50(1):67-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14709637</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 1993 Apr 15;150(8 Pt 1):3448-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7682242</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 1993 Sep 1;178(3):1127-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8350051</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Vet Med Sci. 1998 Jan;60(1):49-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9492360</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Feb;79(4):2079-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15681410</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br Med J. 1967 Sep 23;3(5568):767-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6043624</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2003 May 24;361(9371):1767-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12781535</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 1992 Jul 1;176(1):59-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1613466</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Exp Immunol. 2004 Apr;136(1):95-103</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15030519</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Interferon. 1987;8:55-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2445689</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 1998 Nov 16;17(22):6660-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9822609</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 1999 Dec;14(3):191-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10614856</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2004 Mar;10(3):290-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14981511</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2003 Jul 26;362(9380):293-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12892961</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1960 Aug;46(8):1065-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16590714</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1986 Jan;57(1):328-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2867230</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12711465</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell. 1998 Mar;1(4):507-18</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9660935</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Immunol. 2005;6:2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15655079</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2004 Feb;10(2):294-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15030700</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2001 Jul;64(3):262-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11424113</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Chem. 2003 Jun;49(6 Pt 1):953-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12765993</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2000 Apr;74(7):3404-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10708458</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 1994 Jun 24;264(5167):1918-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8009221</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2003 Oct 10;302(5643):276-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12958366</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10736-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12149435</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2002 Dec 7;360(9348):1831-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12480361</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2003 May 24;361(9371):1773-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12781536</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Virol. 1976;50(4):279-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">179499</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Commun Dis Public Health. 1998 Sep;1(3):202-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9782636</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Biochem. 1998;67:227-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9759489</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2003 Dec 24;290(24):3222-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14693875</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002714 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002714 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:15919935
   |texte=   Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:15919935" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021